cbd
cbd · page 2
- Hemp Industry
DEA Formalises HHC Ban as US Farm Bill Offers No Repreive for Cannabinoid Market
As the federal campaign to clamp down on intoxicating hemp in the US rolls on, the Drug Enforcement Administration (DEA) has officially designated hexahydrocannabinol (HHC) a Schedule I substance.
- CBD Market
The War on Europe’s Legal Hemp Industry
In April 2025, the Italian government used emergency constitutional powers to bypass parliament and reclassify non-intoxicating hemp as a narcotic, regardless of THC content, following multiple failed attempts to decimate the industry.
- CBD Market
CBD Enters US Healthcare Through Medicare Pilot, But Coverage Remains Limited
US Medicare patients have now been given access to cannabidiol (CBD) products through a landmark federal pilot scheme, helping boost cannabis stocks.
- Cultivation
New Zealand’s Medical Cannabis Market Growth Slows as Major Operator Calls in Administrators
New Zealand’s medical cannabis market grew a further 25% in 2025, according to the latest official figures, seeing the country cement its position as one of the lesser-discussed but most exciting markets on the planet.
- CBD Market
Clinical Evidence vs. Food Law: Europe’s CBD Dilemma
The CBD sector has had a turbulent few weeks on both sides of the Channel, with the European Food Safety Authority (EFSA) terminating four novel food applications, just days after announcing incredibly restrictive new safety limits.
- Clinical Research
The Evidence Pyramid: Understanding Cannabis Research
Sorting Evidence from Anecdote As global cannabis research accelerates, the number of published studies has never been higher, but not all evidence carries the same scientific weight.
- Clinical Research
How Cannabis Interacts with Pain, Sleep & Anxiety
Cannabis is now one of the most frequently discussed therapeutic agents in modern medicine, driven by expanding access programmes and a growing demand for alternatives to conventional pharmaceuticals.
- Investment & Finance
Trump Sends Cannabis Stocks Surging, Cantourage Brings in Investor Relations Help, & Mamedica Secures £4.5m
Cannabis Stocks Surge on Trump Video Global cannabis stocks have enjoyed a considerable, but likely temporary, run this week, after US President Donald Trump shared a video apparently endorsing the use of CBD for senior healthcare.
- Opinion
Trump Just Put Cannabinoids Back in the Spotlight — Science Might Finally Catch Up
This opinion piece was written by Calvin Rasode, Vice President, Marketing, Brains Bioceutical When Donald Trump tweets, the world pays attention.
- CBD Market
EU Proposal to Recognise Hemp Flower as a Crop in Landmark Shift for Industry
The European Commission (EC) is considering a major overhaul of regulations surrounding hemp across the Union, potentially marking a step change in how hemp is recognised, traded, and funded.
- CBD Market
Could Starmer’s ‘Brexit Reset’ Drag the CBD Industry Back to Square One?
As part of the FSA’s re-energised efforts to push forward with the long-running CBD novel foods approvals process, the agency has continued to actively liaise with industry stakeholders regarding their applications.
- Uncategorized
FSA Shifts Gears: Reformulation, THC Tolerance, and Faster CBD Approvals Appear to Be On the Horizon
This morning, the UK’s Food Standards Agency (FSA) announced some significant updates to its multi-year CBD Novel Foods approvals process, finally offering hundreds of long-suffering businesses some light at the end of the tunnel.
